Introduction to PK/PD modeling, Brussels (2011)

        2nd Annual Advancing Biologics from the Lab to the Clinic, Amsterdam (2011)


  1. Ben-Gurion University, Beer-Sheva (2009). Pharmacometrics
  2. Tel-Aviv University, Tel-Aviv (2009)
  3. Hebrew University, Jerusalem (2009)
  4. Hadassa, Jerusalem: School of Pharmacy (1998)
  5. Hadassa, Jerusalem: School of Public Health (1998)        
  6. Technion, Haifa: Biomedical Engineering (1998)
  7. Ben GurionUniversity, Beersheva: Clinical Pharmacology (1998)
  8. Teva, Pharmaceutical Company, Natania: Statistical Department (1998)


  1. In Silico Modeling: A Tool To Guide And Optimize Antibody Study Design" Invited speaker at the conference: PEGS , May1-2 2008, Boston,USA.
  2. Applying In Silico PK modeling for Predicting Preclinical Drug Efficacy in Oncology" Invited speaker at the conference: Bridging Pharma and IT Conference , SEPTEMBER 25-27, 2006, Philadephia.
  3. Use of Modeling and Simulation from Preclinical to Commercial Stages: Case Study in Therapeutic Development: Invited speaker at the conference: Bridging Pharma and IT Conference ,SEPTEMBER 25-27, 2006, Philadephia.
  4. IIR’s 3rd Annual Clinical Trial Simulation in Drug Development ,August 2002 (Use Of The MCPEM Algorithm With Simulation Of Complex Covariate Distribution)
  5. CDDS Clinical Trial Simulation Workshop, WashingtonDC (Generalized Algorithm for Simulation of Covariate Joint Densities Using the Conditional Approach for Multivariate Statistical Distributions).
  7. Globomax, Maryland, USA (2002)
  8. Omri pharmaceutical, Netsiona, Israel (2002)
  9. XOMA Corporation, Berkeley (December 2000)
  10. XOMA Corporation, Berkeley (October 2000)
  11. XOMA Corporation, Berkeley (September 2000)
  12. UCB, Pharmaceutical Company, Brussels, Belgium (1996)
  13. Bayer, Pharmaceutical Company, California, USA (1996)
  14. UCB, Public Health, CA, USA (1995)
  15. UCSF, Biostatistic Department, CA, USA (1995)
  16. UCSF, School of Pharmacy, CA, USA (1995)
  17. Roche, Pharmaceutical Company CA, USA (1995)
  18. Burrough Welcome, Pharmaceutical Company, North Carolina, USA (1995)
  19. Glacso, Pharmaceutical Company, North Carolina, USA (1995)
  20. Cancer Research, University of Brussels, Belgium (1994)
  21. Cancer Research Institute, Heidelberg, Germany (1993)
  22. Syntex, Pharmaceutical Company, CA, USA (1993)

To join the mailing list enter your e-mail address:

   Please feel free to subscribe to our mailing list or write to 
  Designed by Studio Sikron